| Literature DB >> 20621835 |
S Portal-Núñez1, D Lozano, L Fernández de Castro, A R de Gortázar, X Nogués, P Esbrit.
Abstract
Type 1 diabetes mellitus (T1D) is associated with bone loss. Given that the Wnt/beta-catenin pathway is a major regulator of bone accrual, we assessed this pathway in mice with streptozotozin-induced T1D. In diabetic mouse long bones, we found alterations favouring the suppression of this pathway by using PCR arrays and beta-catenin immunostaining. Downregulation of sclerostin, an inhibitor of this pathway, also occurred, and related to increased osteocyte apoptosis. Our data show that both N- and C-terminal parathyroid hormone-related peptide fragments might exert osteogenic effects in this setting by targeting several genes of this pathway and increasing beta-catenin in osteoblastic cells. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20621835 DOI: 10.1016/j.febslet.2010.05.047
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124